JY
COYA icon

Jeff Yass’s Coya Therapeutics COYA Stock Holding History

Jeff Yass’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
61,006
+21,690
+55% +$100K ﹤0.01% 10668
2026
Q1 		$155K Sell
39,316
-85,515
-69% -$400K ﹤0.01% 11963
2025
Q4 		$724K Buy
124,831
+91,476
+274% +$556K ﹤0.01% 7949
2025
Q3 		$190K Sell
33,355
-16,795
-33% -$102K ﹤0.01% 11048
2025
Q2 		$288K Sell
50,150
-8,832
-15% -$51.2K ﹤0.01% 10430
2025
Q1 		$382K Buy
58,982
+28,247
+92% +$179K ﹤0.01% 9513
2024
Q4 		$176K Buy
+30,735
New +$209K ﹤0.01% 10865

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Jeff Yass's COYA Position: Q2 2026 in Review

Jeff Yass increased its Coya Therapeutics (COYA) stake by 55% in Q2 2026, buying an estimated $100K and bringing the position to 61,006 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #10668.

Jeff Yass first reported a position in COYA in Q4 2024 and has held it in 7 quarters since. The position peaked at $724K in Q4 2025. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Jeff Yass held 61,006 shares of Coya Therapeutics worth $357K as of Q2 2026.
  • Jeff Yass bought 21,690 Coya Therapeutics shares in Q2 2026, an estimated $100K.
  • Coya Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10668 holding.
  • Jeff Yass first reported a position in Coya Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Jeff Yass's Coya Therapeutics position peaked at $724K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.